These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38423295)

  • 41. Clinical and Molecular Diagnostic Evaluation of Systemic Mastocytosis in the South-Eastern Hungarian Population Between 2001-2013--A Single Centre Experience.
    Marton I; Krenács L; Bagdi E; Bakos A; Demeter J; Borbényi Z
    Pathol Oncol Res; 2016 Apr; 22(2):293-9. PubMed ID: 26545382
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User's Guide for Daily Clinical Practice.
    Valent P; Hartmann K; Schwaab J; Alvarez-Twose I; Brockow K; Bonadonna P; Hermine O; Niedoszytko M; Carter MC; Hoermann G; Sperr WR; Butterfield JH; Ustun C; Zanotti R; Radia DH; Castells M; Triggiani M; Schwartz LB; Orfao A; George TI; Sotlar K; Gotlib J; Reiter A; Horny HP; Arock M; Akin C; Metcalfe DD
    J Allergy Clin Immunol Pract; 2022 Aug; 10(8):1999-2012.e6. PubMed ID: 35342031
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management.
    Pardanani A
    Am J Hematol; 2013 Jul; 88(7):612-24. PubMed ID: 23720340
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gene expression profile of highly purified bone marrow mast cells in systemic mastocytosis.
    Teodosio C; García-Montero AC; Jara-Acevedo M; Sánchez-Muñoz L; Pedreira CE; Álvarez-Twose I; Matarraz S; Morgado JM; Bárcena P; Matito A; Mayado A; Sanchez ML; Diez-Campelo M; Escribano L; Orfao A
    J Allergy Clin Immunol; 2013 Apr; 131(4):1213-24, 1224.e1-4. PubMed ID: 23403045
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Underlying systemic mastocytosis in patients with unexplained osteoporosis: score proposal.
    Tanasi I; Crosera L; Taus F; Orsolini G; Adami G; Olivieri F; Bernardelli A; Bonadonna P; Nalin F; Sella S; Giannini S; Liu Y; Mannelli F; Vanderwert F; Bonifacio M; Krampera M; Rossini M; Lyons JJ; Zanotti R
    Bone; 2024 Sep; 186():117141. PubMed ID: 38823568
    [TBL] [Abstract][Full Text] [Related]  

  • 46. KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients.
    Garcia-Montero AC; Jara-Acevedo M; Teodosio C; Sanchez ML; Nunez R; Prados A; Aldanondo I; Sanchez L; Dominguez M; Botana LM; Sanchez-Jimenez F; Sotlar K; Almeida J; Escribano L; Orfao A
    Blood; 2006 Oct; 108(7):2366-72. PubMed ID: 16741248
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Osteoporosis with vertebral fractures in young males, due to bone marrow mastocytosis: a report of two cases.
    Manara M; Varenna M; Cantoni S; Parafioriti A; Gallazzi MB; Sinigaglia L
    Clin Exp Rheumatol; 2010; 28(1):97-100. PubMed ID: 20346248
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A clinicopathologic study of 24 cases of systemic mastocytosis involving the gastrointestinal tract and assessment of mucosal mast cell density in irritable bowel syndrome and asymptomatic patients.
    Doyle LA; Sepehr GJ; Hamilton MJ; Akin C; Castells MC; Hornick JL
    Am J Surg Pathol; 2014 Jun; 38(6):832-43. PubMed ID: 24618605
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms.
    Valent P; Sperr WR; Schwartz LB; Horny HP
    J Allergy Clin Immunol; 2004 Jul; 114(1):3-11; quiz 12. PubMed ID: 15241337
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Precision Medicine in Systemic Mastocytosis.
    Nicolosi M; Patriarca A; Andorno A; Mahmoud AM; Gennari A; Boldorini R; Gaidano G; Crisà E
    Medicina (Kaunas); 2021 Oct; 57(11):. PubMed ID: 34833353
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systemic mastocytosis in adults: 2015 update on diagnosis, risk stratification, and management.
    Pardanani A
    Am J Hematol; 2015 Mar; 90(3):250-62. PubMed ID: 25688753
    [TBL] [Abstract][Full Text] [Related]  

  • 52. KITD816V mutation in blood for the diagnostic screening of systemic mastocytosis and mast cell activation syndromes.
    Navarro-Navarro P; Álvarez-Twose I; Pérez-Pons A; Henriques A; Mayado A; García-Montero AC; Sánchez-Muñoz L; González-López O; Matito A; Caldas C; Jara-Acevedo M; Orfao A
    Allergy; 2023 May; 78(5):1347-1359. PubMed ID: 36385619
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis.
    Morgado JM; Perbellini O; Johnson RC; Teodósio C; Matito A; Álvarez-Twose I; Bonadonna P; Zamò A; Jara-Acevedo M; Mayado A; Garcia-Montero A; Mollejo M; George TI; Zanotti R; Orfao A; Escribano L; Sánchez-Muñoz L
    Histopathology; 2013 Dec; 63(6):780-7. PubMed ID: 24111625
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Standards of Pathology in the Diagnosis of Systemic Mastocytosis: Recommendations of the EU-US Cooperative Group.
    Sotlar K; George TI; Kluin P; Reiter A; Schwaab J; Panse J; Brockow K; Hartmann K; Sperr WR; Kristensen T; Nedoszytko B; Carter M; Bonadonna P; Lyons JJ; Kluin-Nelemans HC; Hermine O; Akin C; Broesby-Olsen S; Hoermann G; Triggiani M; Butterfield JH; Jawhar M; Gotlib J; Metcalfe DD; Orfao A; Arock M; Valent P; Horny HP
    J Allergy Clin Immunol Pract; 2022 Aug; 10(8):1986-1998.e2. PubMed ID: 35724949
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mastocytosis.
    Brockow K; Metcalfe DD
    Chem Immunol Allergy; 2010; 95():110-124. PubMed ID: 20519885
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Systemic Mastocytosis: Advances in Diagnosis and Current Management.
    Pullarkat ST; Wu W; Pullarkat V
    Cancer Treat Res; 2021; 181():167-178. PubMed ID: 34626361
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Delineation of patterns of bone marrow mast cell infiltration in systemic mastocytosis: value of CD25, correlation with subvariants of the disease, and separation from mast cell hyperplasia.
    Krokowski M; Sotlar K; Krauth MT; Födinger M; Valent P; Horny HP
    Am J Clin Pathol; 2005 Oct; 124(4):560-8. PubMed ID: 16146815
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mastocytosis in the skin in dogs: A multicentric case series.
    Wyatt EK; Affolter V; Borio S; Guillen A; Verganti S; Murphy S; Ballarini D; Banovic F; Schmidt V; Tanis JB
    Vet Comp Oncol; 2024 Mar; 22(1):136-148. PubMed ID: 38243867
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Systemic mastocytosis: A cohort study on clinical characteristics of 136 patients in a large tertiary centre.
    Hermans MAW; Rietveld MJA; van Laar JAM; Dalm VASH; Verburg M; Pasmans SGMA; Gerth van Wijk R; van Hagen PM; van Daele PLA
    Eur J Intern Med; 2016 May; 30():25-30. PubMed ID: 26809706
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An Unusual Transition from Cutaneous to Systemic Mastocytosis in a Pediatric Patient.
    Patel K; Cuervo-Pardo L; Cresoe S; Cavero-Chavez V
    Pediatr Allergy Immunol Pulmonol; 2023 Dec; 36(4):150-152. PubMed ID: 38134319
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.